This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Mar;13(3):188-9.

doi: 10.1016/S1473-3099(13)70027-6. Epub 2013 Jan 29.

No easy route to a pandemic influenza vaccine

Sarah C Gilbert¹

Affiliations

PMID: 23369411
DOI: 10.1016/S1473-3099(13)70027-6

Comment

No easy route to a pandemic influenza vaccine

Sarah C Gilbert. Lancet Infect Dis. 2013 Mar.

. 2013 Mar;13(3):188-9.

doi: 10.1016/S1473-3099(13)70027-6. Epub 2013 Jan 29.

Author

Sarah C Gilbert¹

Affiliation

¹ Jenner Institute, University of Oxford, Oxford OX3 7DQ, UK. sarah.gilbert@ndm.ox.ac.uk

PMID: 23369411
DOI: 10.1016/S1473-3099(13)70027-6

No abstract available

PubMed Disclaimer

Comment on

Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study.
Gurwith M, Lock M, Taylor EM, Ishioka G, Alexander J, Mayall T, Ervin JE, Greenberg RN, Strout C, Treanor JJ, Webby R, Wright PF. Gurwith M, et al. Lancet Infect Dis. 2013 Mar;13(3):238-50. doi: 10.1016/S1473-3099(12)70345-6. Epub 2013 Jan 29. Lancet Infect Dis. 2013. PMID: 23369412 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information